4[4]Pahl A,Szelenyi I.Asthma therapy in the new millemlium[J].Inflamm Res,2002,51(3):273-282.
5[5]Lin CC,Lin CY,Liaw SF,et al.Pulmonary function changes and immunomodulation of Th2 cytoltine expression induced by aminophylline after sensitization and allergen challenge in brown Norwan rats[J].Allergy Asthma immunol,2002,88(2):215-222.
4[2]Shimizu E, Nakaura Y, Mukai J,et al. Pharmacokinetics of bronchial artery infusion of mitomycin in patients with non-small cell lung cancer. Eur J Cancer, 1991, 27:1046
5[3]He JG, Song HZ, Yan XF. Interventional treatment of non-operable central lung cancer. Chung Hua Wai Ko Tsa Chih, 1994, 32:106
6[4]Shinozaki Y, Hara F, Mushiake H,et al. Evaluation of new style of drug delivery system for primary lung cancer: Intermittent intra-arterial injection therapy with subcutaneous infusible port I. Temporary change in feeding arteries of lung cancer in processes of intra-arterial injection therapy. Gan To Kagaku Ryoho, 1995, 22:77
7[5]Masuda H, Makita K, Nakajima T,et al. Chest wall implanted reservoir for bronchial arterial infusion of antineoplastic agents in high-aged lung cancer patients. Jpn J Thorac Cardiovase Surg, 1999, 47:124
9[7]Motecki T, Ohya N, Katsuya T. Bronchial arterial angio-CT: Evaluation of intradural and oesophageal enhancement before bronchial arterial infusion. Br J Radiol, 1998, 71:834
10[2]Madajiewicz S,Chowhan N,Tfayli A,et al.Therapy for patients with high grad astrocytoma using intraarterial chemothererapy and radiation therpy[J].Cancer,2000,88 (10):2350 ～2356.
